Description
Cell line name NCC-LGFMS1-C1
Accession CVCL_B0W9
Resource Identification Initiative To cite this cell line use: NCC-LGFMS1-C1 (RRID:CVCL_B0W9)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: ~149.9 hours (PubMed=34535876).
Omics: SNP array analysis.
Derived from site: In situ; Rectus abdominis muscle; UBERON=UBERON_0002382.
Sequence variations
Gene fusion; HGNC; 23720; CREB3L2 + HGNC; 4010; FUS; Name(s)=FUS-CREB3L2 (PubMed=34535876).
Disease Low grade fibromyxoid sarcoma (NCIt: C45202)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 45Y
Category Cancer cell line
STR profile
Source(s): PubMed=34535876
Markers:
Amelogenin | X |
CSF1PO | 11,12 |
D5S818 | 11,12 |
D7S820 | 10,11 |
D13S317 | 10,12 |
D16S539 | 9,13 |
D21S11 | 29,33.2 |
TH01 | 7,8 |
TPOX | 8,11 |
vWA | 17,18 |
Publications
PubMed=34535876; DOI=10.1007/s13577-021-00612-1
Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T., Sei A., Sugaya J., Iwata S., Yoshida A., Kawai A., Kondo T.
Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma.
Hum. Cell 34:1919-1928(2021)
Cross-references
Encyclopedic resources Wikidata; Q108821013
Reviews
There are no reviews yet.